Pre-made Enapotamab Vedotin benchmark antibody (Whole mAb ADC, anti-AXL therapeutic antibody, Anti-ARK/JTK11/Tyro7/UFO Antibody) for drug discovery and mechanism of action (MOA) research

Cat No.: GMP-Bios-INN-832

Pre-made Enapotamab Vedotin benchmark antibody (Whole mAb ADC, anti-AXL therapeutic antibody, Anti-ARK/JTK11/Tyro7/UFO Antibody) is a biosimilar expressed by mammalian cell line as a benchmark reference therapeutic antibody for biological drug disovery items including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.



Order information


* GeneMedi provides NON-PROFIT PRICE to support Academic research. Please click inquiry for product quotation. → Inquiry

Catalog No. Package Price(In USD) Qty (Quantity) Sum(In USD)
GMP-Bios-INN-832-1mg 1mg 4635
GMP-Bios-INN-832-10mg 10mg Inquiry
GMP-Bios-INN-832-100mg 100mg Inquiry
GMP-Bios-INN-832-xmg ≥100mg Inquiry
Shipping Cost: 760.00
Total:



Description

Products Name (INN Index) Pre-Made Enapotamab Vedotin Biosimilar, Whole Mab Adc, Anti-Axl Antibody: Anti-ARK/JTK11/Tyro7/UFO therapeutic antibody Drug Conjugate
INN Name Enapotamab Vedotin
TargetAXL
FormatWhole mAb ADC
Derivationhuman
Species Reactivityhuman
CH1 IsotypeIgG1 - kappa
VD LCIgG1 - kappa
Highest_Clin_Trial (Jan '20)
Est. Status
100% SI Structure
99% SI Structure
95-98% SI Structure
Year Proposed
Year Recommended
CompaniesGenmab A/S (Copenhagen Denmark)
Conditions Approved
Conditions Active
Conditions Discontinued
Development Tech0